Inflammation is critical to atherosclerosis. Psoriasis, a chronic inflammatory disease associated with early cardiovascular events and increased aortic vascular inflammation (VI), provides a model to study the process of early atherogenesis. Fludeoxyglucose F 18 positron emission tomography/computed tomography ( 18 F-FDG PET/CT) helps quantify aortic VI, and coronary computed tomography angiography provides coronary artery disease (CAD) assessment through evaluation of total plaque burden (TB) and noncalcified coronary plaque burden (NCB), luminal stenosis, and high-risk plaques (HRP). To our knowledge, association between aortic VI and broad CAD indices has not yet been assessed in a chronic inflammatory disease state. Such a study may provide information regarding the utility of aortic VI in capturing early CAD.
I nflammation is increasingly recognized as a driver of atherosclerosis. 1 From early endothelial cell dysfunction to late-stage coronary plaque rupture, inflammatory mediators have a critical role in the atherosclerotic cascade. 2 Psoriasis, a chronic inflammatory skin disorder, is associated with heightened cardiovascular risk, increased vascular inflammation (VI), and increased incidence of early cardiovascular events including myocardial infarction and stroke. [3] [4] [5] [6] Psoriasis being a systemic inflammatory state may therefore help understand the role of chronic inflammation in atherosclerosis in vivo.
In 2017 and 2018, findings from the Canakinumab Antiinflammatory Thrombosis Outcomes Study (CANTOS), 7, 8 inflammation reduction was demonstrated to reduce cardiovascular events in direct proportion with the extent of highsensitivity C-reactive protein reduction, despite null effects on lipids. While these findings highlight the role of residual inflammatory risk in atherosclerosis, emerging imaging techniques provide means to assess inflammation within the vasculature and effect on atherosclerotic plaque development and progression. Aortic vascular inflammation by fluorodeoxyglucose F 18 positron emission tomography computed tomography ( 18 F-FDG PET/CT) has been used as a surrogate marker of cardiovascular risk and immune-mediated vascular disease during the last decade. 9, 10 Histologic studies corroborate that aortic VI by 18 F-FDG PET/CT is associated with the activity of proinflammatory CD-68 macrophages within the arterial wall. 11 Aortic VI is associated with hard cardiovascular events, improves cardiovascular risk prediction, 12 and is also amenable to modulation, with known risk-modifying agents including statins, anti-inflammatory therapies, and therapeutic lifestyle changes. [13] [14] [15] [16] However, its context in treatment trials as a quantifiable primary end point is only now gaining momentum. Furthermore, how aortic VI is associated with vascular diseases in other territories, including the coronary arteries, is understudied. A prior study characterized the association between aortic VI and high-risk coronary plaque (HRP) morphology in patients with HIV 17 and found that aortic VI was associated with coronary artery disease. To our knowledge, whether aortic VI is associated with broad coronary plaque characteristics has not been evaluated. Coronary computed tomography angiography (CCTA) is an important imaging tool for the assessment of coronary plaque. 18 Coronary computed tomography angiography provides qualitative assessment of coronary plaque composition and allows for the volumetric quantification of the burden of coronary artery disease (CAD) 19-21 while sparing the risks of invasive assessment tools. 22 Noncalcified coronary plaque burden (NCB)
by CCTA has been shown to associate with thin cap fibroatheroma by histological evaluation 23 and is elevated in psoriasis. 21 Furthermore, noncalcified plaques are known to be the culprit lesion in most ST-segment elevation myocardial infarction. [23] [24] [25] Total coronary plaque burden (TB) and NCB by CCTA are beneficial in the prediction of prospective cardiovascular outcomes. 26, 27 Additionally, CCTA also provides a reliable tool to characterize the lipid-rich, rupture-prone HRPs, which associate with an increased risk of prospective cardiovascular events. 24 We have previously demonstrated that psoriasis is associated with a higher prevalence of such HRPs compared with age-and sex-matched healthy volunteers, to a similar extent as seen in hyperlipidemic patients 10 years older. 21 Here, we used an ongoing cohort study of patients with psoriasis and leveraged multimodality imaging using 18 F-FDG PET/CT and CCTA. Our goal was to analyze the association between aortic VI ( Figure 1A) and CCTA-based quantitative and qualitative CAD indices including TB and NCB, luminal stenosis, and HRP characteristics ( Figure 1B ). We hypothesized that there would be a direct association between aortic VI and CAD indices.
Methods
This study consisted of a cohort of consecutive patients with psoriasis (n = 215), all of whom were recruited between January 1, 2013, and May 31, 2017, and underwent 18 F-FDG PET/CT. Of 215 patients, 25 patients did not undergo CCTA scans owing to the unavailability of scanners on their specific visit dates; thus, 190 patients had CCTA scans ( Figure 2) . Of 190 patients with CCTA, 182 scans (546 arteries) were interpretable and were included in the final analysis for quantitative plaque burdens. Furthermore, for analyses of luminal stenoses, scan reads were available for 171 patients (513 arteries), while HRP characterization was available in 169 patients (507 arteries). Coronary plaque burden was evaluated across 3 major epicardial coronary arteries using the dedicated software QAngio CT (Medis) by previously described methods.
19 Semiautomated segmentation of each major coronary artery was performed. The need for manual adjustment was reviewed by assessing transverse reconstructed cross-sections at 0. F-FDG PET/CT assessed as target-tobackground ratio (TBR) and other cardiovascular risk factors. All participants provided written informed consent. The study protocols were approved by the institutional review board at the National Institutes of Health. All study protocols are in compliance with the Declaration of Helsinki.
Multivariable linear regressions were performed to examine the association between aortic VI and TB, NCB, and densecalcified plaque. Standardized β values from these analyses were reported, which indicate number of SD change in the outcome variable (TB or NCB) per SD change in the exposure (aortic VI). Multivariable logistic regressions assessed the aortic VI-luminal stenosis and aortic VI-HRP associations, whereas ordered logistic regressions were used for studying the luminal stenosis severity-aortic VI as well as HRP scoreaortic VI associations. Odds ratios (ORs) with 95% confidence intervals were reported for all logistic regression analyses. Detailed methods, including the comprehensive imaging protocols, image analyses protocols, covariate determinations, and statistical analyses, are provided in the eMethods in the Supplement. A 2-sided P value of less than .05 was considered statistically significant.
Results

Characteristics of the Study Group at Baseline
We summarize the characteristics of our study population in ). A total of 82 patients (163 arteries) of 171 (513 arteries) evaluated had greater than 25% luminal stenosis. Finally, 57 patients of 169 evaluated had prevalent HRP in at least 1 major epicardial coronary artery.
Association Between Aortic VI and CAD
We compared the patients with psoriasis with TBR at the median or higher (1.66) with those with TBR less than the median to assess whether coronary findings tracked alongside TBR. Patients with psoriasis with higher TBR (mean [ Although both subgroups had low atherosclerotic cardiovascular disease 10-year risk, patients with higher TBR had increased atherosclerotic cardiovascular disease risk (3.5; IQR, 1.6-7.9 vs 1.5; IQR, 0.4-4.4; P < .001) compared with the other subgroup. Finally, despite similar psoriasis duration, patients with higher TBR had elevated insulin resistance and increased levels of high-sensitivity C-reactive protein concomitant with increased psoriasis severity.
On comparing the CCTA-based characteristics, quantitative TB was increased in patients with higher TBR (mean [ P < .001). Furthermore, severity of luminal stenosis was significantly worse in patients with higher TBR (P = .002). Finally, HRP prevalence was higher in those with higher TBR (42% vs 26%, P = .02). The distribution of HRP score differed significantly between 2 groups and was driven by the difference in LAP score, while PRP scores were essentially similar ( Table 2) . Similar analyses were performed to test whether the reverse was true for TBR, which demonstrated increased TBR in patients with luminal stenosis as well as in patients with presence of HRP compared with those without (eTables 1 and 2intheSupplement).
Association of Aortic VI With Quantitative Total and Noncalcified Coronary Plaque Burden, Luminal Stenosis, and High-Risk Plaque Characteristics
Subsequent analyses showed that aortic VI was associated with both TB (β = 0.48; P < .001) and NCB (β = 0.49; P < .001) ( Table 3) . This association persisted after adjustment for age, sex, BMI, diabetes, hypertension, smoking, hyperlipidemia, lipid-lowering treatment with statins, high-sensitivity C-reactive protein, and psoriasis treatment with systemic/biologic agents (TB, β = 0.23; P < .001 and NCB, β = 0.24; P < .001) (eFigure 1 in the Supplement). No such association was observed for dense-calcified burden (eFigure 2 in the Supplement). For each 1-SD unit increase in aortic VI, we observed a 20% increase in NCB in unadjusted analyses and 10% higher NCB in fully adjusted analyses. Furthermore, aortic VI was associated with luminal stenosis in both unadjusted (OR, 3.63; 95% CI, 1.71-7.70; P = .001) and fully adjusted (OR, 3.40; 95% CI, 1.40-8.24; P = .007) analyses (eTable 3 in the Supplement). Analogous results were found for luminal stenosis severity (unadjusted OR, 4.03; 95% CI, 1.90-8.55; P < .001 and fully adjusted OR, 3.38; 95% CI, 1.42-8.07; P = .006). Per 1-SD increase in VI was associated with significantly increased odds of prevalent luminal stenosis (unadjusted, 1.38 and adjusted, 1.36) and severity of luminal stenosis (unadjusted, 1.42 and adjusted, 1.36). Finally, we also observed an association between aortic VI and HRP prevalence (OR, 3.05; 95% CI, 1.48-6.29; P = .002) that persisted beyond full adjustment (OR, 2.72; 95% CI, 1.08-6.83; P = .03) (eTable 4 in the Supplement). Similarly, aortic VI was also associated with HRP score (unadjusted OR, 3.03; 95% CI, 1.42-6.47; P = .004 and fully adjusted OR, 2.95; 95% CI, 1.21-7.18; P = .02), which was primarily driven by an association with LAP score (unadjusted OR, 5.63; 95% CI, 1.96-16.19; P = .001 and fully adjusted OR, 6.33; 95% CI, 1.88-21.28; P = .003), whereas PRP score did not associate with aortic VI (unadjusted OR, 1.51; 95% CI, 0.64-3.58; P = .70). Ultimately, per 1-SD increase in VI was associated with increased HRP prevalence at 1.34 times increased odds in unadjusted and 1.3 times increased odds in fully adjusted analyses.
Discussion
Major Findings
Our analysis of aortic VI by 18 F-FDG PET/CT and CAD indices by CCTA demonstrates the following findings: (1) when stratified by high aortic VI, the extent of CAD is greater in those with elevated aortic VI, in line with greater quantitative total CAD burden, increased prevalence of luminal stenoses, more severe luminal stenosis, and a higher prevalence of HRP; (2) the increase in TB is predominantly driven by NCB, whereas dense-calcified burden does not differ by varying degrees of aortic VI; and (3) In this study, we demonstrated an association between aortic VI and TB as well as between aortic VI and NCB, both of which persisted beyond adjustment for traditional risk factors, signifying that the presence of early vascular disease may in part be comparable across multiple major vascular beds. Interestingly, dense-calcified coronary plaque burden was not associated with aortic VI, which upheld the notion that aortic VI maybe a marker of early vascular disease. 9 Furthermore, we demonstrated that aortic VI was directly associated with presence as well as severity of luminal stenosis in major epicardial coronary arteries, denoting aortic VI as a clinically reliable indicator of CAD. Finally, aortic VI was associated with HRP prevalence and HRP score in patients with psoriasis. This was principally driven by the association between aortic VI and LAP, whereas the association between aortic VI and PRP was statistically nonsignificant. While this is a biologically interesting finding, caution needs to be exercised in interpreting this result because the absolute number of PRP was small in our study. Taken together, these findings suggest that aortic VI may be a potential surrogate marker for the evaluation of early CAD. Finally, building on the prior literature, these associations suggest that the inflammatory processes captured by 18 F-FDG PET/CT may be implicated in the development as well as progression of coronary atherosclerosis. 35 
Strengths and Limitations
Despite our significant findings, our study does have notable limitations. We lack hard cardiovascular outcomes. The small sample size, observational nature of our study, and crosssectional analyses preclude any attempt at establishing causality and also make our analyses prone to unmeasured confounding. When imaging targets of small size, such as atherosclerotic plaques, the spatial resolution limitations of PET imaging create a close association between lesion size and the apparent lesion intensity. 36,37 Thus, an interaction is possible between apparent plaque size measured by CT and standardized tracer activity of the aorta, considering that larger individuals will have larger coronary arteries and aortic wall sizes. To attenuate such an interaction, we included adjustment for BMI within our multivariable model and still observed significance in the association between CAD indices and aortic VI, albeit with attenuated strength. Another limitation of our study is that VI was assessed in the aorta and not in the coronary arteries. There are several technical hurdles in attempting to assess coronary inflammation by PET. Electrocardiogram and respiratory motion gating were not available for 18 F-FDG PET/ CT, thus precluding fusion of coronary PET imaging with CCTA; 
Implications and Future Directions
Our findings build on previous evidence of an association between VI in the aortic arch by PET and LAP by CCTA in an inflammatory condition (eg, HIV). 17 We confirm this association using VI from the entire aorta and also extend these findings by providing further evidence for an association between aortic VI and coronary plaque burden and composition, including the whole vessel NCB, HRP prevalence, and HRP subtypes. These findings are potentially generalizable to other inflammatory diseases but would need to be confirmed in noninflammatory states using larger generalizable cohorts in longitudinal studies. Additionally, future studies should use multimodality imaging, including CCTA concurrent with 18 F-FDG PET/CT, to investigate the effect of reducing inflammation on atherosclerosis in various vascular beds.
Conclusions
Our findings demonstrate that aortic VI by 18 F-FDG PET/CT is associated with multiple indices of coronary plaque extent and composition derived from CCTA. This provides evidence that aortic VI by 18 F-FDG PET/CT may be a potential surrogate for assessment of early CAD captured by CCTA. Larger studies assessing these associations over longer periods of time are warranted. Concurrent use of multimodality imaging should assess whether targeted therapies to curb inflammation affect early vascular disease in the aorta and coronary arteries. Abbreviations: BMI, body mass index; hsCRP, high-sensitivity C-reactive protein. 
Aortic Vascular Inflammation and Coronary Artery Disease in Psoriasis
METHODS AND MATERIALS
Study Population, and Inclusion/Exclusion Criteria Participants were >18 years of age; psoriasis patients were required to have a formal diagnosis of plaque psoriasis for study inclusion. A trained healthcare provider evaluated all patients with psoriasis for the assessment of psoriasis skin disease severity measured as a psoriasis area severity index (PASI) score. Exclusion criteria included estimated glomerular filtration rate <30 mL/minute/1.73 m 2 , pregnancy, lactation in female patients and any comorbid condition known to promote cardiovascular disease or systemic inflammation; such as clinically diagnosed cardiovascular disease, uncontrolled hypertension, internal malignancy within 5 years, human immunodeficiency virus, active infection within the past 72 hours of baseline, and major surgery within 3 months.
Analysis of Aortic Vascular Inflammation by
18 FDG PET/CT All patients underwent 18 FDG PET/CT scans. All scans were read in a blinded fashion to patient characteristics and imaging time point. Images were analyzed using a dedicated PET CT analysis program (Extended Brilliance Workspace; Phillips Healthcare) to quantify vascular inflammation (VI) measured as target-to-background ratio 1, 2 . Patients underwent 18 FDG PET/CT scans following an overnight fast. Images were acquired approximately 60 minutes after administration of 10 mCi 18 FDG. Imaging was performed using a Siemens Biograph mCT PET/CT 64-slice scanner (Siemens Medical Solutions USA, Malvern, PA, USA). Standard bed positions of three minutes each, scanning cranially to caudally were obtained for each patient from the vertex to the toes. 1.5mm thick axial slices of aorta were used to measure uptake of 18 FDG in the aortic wall from its origin as ascending aorta from the aortic outflow tract to its bifurcation into iliac arteries. Two measures of metabolic activity, mean standardized uptake value and maximal standardized uptake value were obtained by placing regions of interest in the entire aorta. Similar regions of interest were placed on 10 contiguous superior vena cava slices, and an average of the mean standardized uptake values from these 10 slices was used as the blood activity which served as the background. Target-to-background ratio was derived from each aortic slice by dividing the maximal standardized uptake values by the average venous mean standardized uptake value and was then averaged over the total number of slices yielding a single value that was used as a measure of aortic VI in each patient. In this study, we present data only from the aorta. Data pertinent to other arteries will be reported separately.
hypertension and diabetes. Patient responses were confirmed by interview with the study provider. Cardiovascular disease included acute coronary syndrome comprising both MI and unstable angina pectoris, stable angina pectoris, cerebrovascular event, transient ischemic attack, peripheral vascular disease and revascularization procedures that comprised of coronary artery bypass grafting and percutaneous interventional procedures. Diabetes and hypertension were defined either by an established diagnosis or by use of glucose lowering and blood pressure lowering drugs, respectively.
Statistical Analyses
Summary statistics were generated for patient groups. Continuous data were reported as mean±S.D. for parametric variables and as median with interquartile range for non-parametric variables, whereas categorical variables were reported as frequencies. Normality was assessed by skewness and kurtosis. Comparisons between stratified groups were performed using student's ttests for parametric continuous data while non-parametric data was compared using MannWhitney U tests. Categorical variables were compared using Pearson's chi-squared tests. Multivariable linear regression analyses were performed to evaluate the association between VI by 18 FDG PET/CT derived target-to-background ratios and TB and NCB burden adjusting for confounding covariates. We also checked for homoscedasticity of residuals and found constant residual variance. Standardized beta co-efficient and p-values were reported for all linear regression analyses. Multivariable logistic regression analyses were implemented for analyzing the association between VI and presence of luminal stenoses as well as HRP. Finally, for the assessment of the association between various severities of luminal stenoses as well as HRP scores and HRP subtype scores and VI, ordered logistic regression was employed. Postestimation tests such as likelihood-ratio testing and Brant test were used to confirm the proportional odds assumption for the ordered logistic regression analyses, and where the assumption was violated, generalized ordered logistic regression was performed. Odds ratio with 95% confidence intervals were reported for all logistic regression analyses.
We hypothesized an additional effect of 0.15 of VI in the adjusted R-squared for fully adjusted model assessing the association between VI and NCB. Thus, our sample size of 182 patients provided us a power greater than 90% to detect this association with statistical significance. Furthermore, for our secondary analyses encompassing the associations between luminal stenosis and VI as well as HRP and VI, our respective sample sizes of 171 and 169 patients were sufficient to detect these associations with >90% power for odds ratios between 2.0 and 4.0. All statistical analyses were performed using STATA version 12 (StataCorp, College Station, TX, USA), p<0.05 was considered for determining statistical significance. 
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